| Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification S Takase, S Kano, Y Tada, D Kawakita, T Shimura, H Hirai, K Tsukahara, ... Oncotarget 8 (35), 59023, 2017 | 96 | 2017 |
| Clinical outcomes and prognostic factors for salivary duct carcinoma: a multi-institutional analysis of 141 patients K Otsuka, Y Imanishi, Y Tada, D Kawakita, S Kano, K Tsukahara, ... Annals of surgical oncology 23, 2038-2045, 2016 | 95 | 2016 |
| Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas T Shimura, Y Tada, H Hirai, D Kawakita, S Kano, K Tsukahara, A Shimizu, ... Oncotarget 9 (2), 1852, 2018 | 43 | 2018 |
| PLOD2 is essential to functional activation of integrin β1 for invasion/metastasis in head and neck squamous cell carcinomas Y Ueki, K Saito, H Iioka, I Sakamoto, Y Kanda, M Sakaguchi, A Horii, ... IScience 23 (2), 2020 | 33 | 2020 |
| Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan D Kawakita, Y Tada, Y Imanishi, S Beppu, K Tsukahara, S Kano, H Ozawa, ... Oncotarget 8 (1), 1083, 2017 | 32 | 2017 |
| Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma D Kawakita, T Nagao, H Takahashi, S Kano, Y Honma, H Hirai, N Saigusa, ... Therapeutic Advances in Medical Oncology 14, 17588359221119538, 2022 | 23 | 2022 |
| Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy R Shodo, K Yamazaki, Y Ueki, T Takahashi, A Horii European Archives of Oto-Rhino-Laryngology 278, 2001-2009, 2021 | 23 | 2021 |
| Prognostic implication of histopathologic indicators in salivary duct carcinoma: proposal of a novel histologic risk stratification model M Nakaguro, Y Sato, Y Tada, D Kawakita, H Hirai, M Urano, T Shimura, ... The American journal of surgical pathology 44 (4), 526-535, 2020 | 23 | 2020 |
| Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified … Y Ueki, T Takahashi, H Ota, R Shodo, K Yamazaki, A Horii European Archives of Oto-Rhino-Laryngology 277, 2341-2347, 2020 | 19 | 2020 |
| Near‐infrared fluorescence imaging in the identification of parathyroid glands in thyroidectomy T Takahashi, K Yamazaki, H Ota, R Shodo, Y Ueki, A Horii The Laryngoscope 131 (5), 1188-1193, 2021 | 18 | 2021 |
| The association between oral candidiasis and severity of chemoradiotherapy-induced dysphagia in head and neck cancer patients: A retrospective cohort study H Saito, R Shodo, K Yamazaki, K Katsura, Y Ueki, T Nakano, T Oshikane, ... Clinical and translational radiation oncology 20, 13-18, 2020 | 15 | 2020 |
| Actual prevalence of hypoparathyroidism after total thyroidectomy: a health insurance claims-database study T Takahashi, K Yamazaki, R Shodo, Y Ueki, A Horii Endocrine 78 (1), 151-158, 2022 | 12 | 2022 |
| Comparison of autofluorescence with near‐infrared fluorescence imaging between primary and secondary hyperparathyroidism M Takeuchi, T Takahashi, R Shodo, H Ota, Y Ueki, K Yamazaki, A Horii The Laryngoscope 131 (6), E2097-E2104, 2021 | 12 | 2021 |
| Cervical spine osteomyelitis and epidural abscess after chemoradiotherapy for hypopharyngeal carcinoma: a case report Y Ueki, J Watanabe, S Hashimoto, S Takahashi Case Reports in Otolaryngology 2014 (1), 141307, 2014 | 12 | 2014 |
| The role of the EZH2 and H3K27me3 expression as a predictor of clinical outcomes in salivary duct carcinoma patients: a large-series study with emphasis on the relevance to the … N Saigusa, H Hirai, Y Tada, D Kawakita, M Nakaguro, K Tsukahara, ... Frontiers in Oncology 11, 779882, 2022 | 11 | 2022 |
| Treatment outcome of external auditory canal carcinoma: the utility of lateral temporal bone resection K Saijo, Y Ueki, R Tanaka, Y Yokoyama, J Omata, T Takahashi, H Ota, ... Frontiers in Surgery 8, 708245, 2021 | 11 | 2021 |
| Role of programmed death‐ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma Y Ueki, T Takahashi, H Ota, R Shodo, K Yamazaki, A Horii Head & neck 42 (11), 3275-3281, 2020 | 11 | 2020 |
| The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma H Hirai, Y Tada, M Nakaguro, D Kawakita, Y Sato, T Shimura, ... Virchows Archiv 477, 291-299, 2020 | 11 | 2020 |
| Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in Japan H Matsuyama, K Yamazaki, R Okabe, Y Ueki, R Shodo, J Omata, Y Sato, ... Auris Nasus Larynx 45 (5), 1086-1092, 2018 | 11 | 2018 |
| The high expression of FOXA 1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases M Urano, H Hirai, Y Tada, D Kawakita, T Shimura, K Tsukahara, S Kano, ... Histopathology 73 (6), 943-952, 2018 | 10 | 2018 |
